Intelligence · Clinical Development
Pipeline search results
Programs matching “citalopram” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 17 pipeline programs matching "citalopram" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Escitalopram
Otsuka Beijing Research Institute
Major Depressive Disorder (MDD)
1 trial -
Escitalopram
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Dependence
1 trial -
Escitalopram
Takeda
Major Depressive Disorder
1 trial -
Escitalopram
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Mild-to-moderate Depression
1 trial -
Citalopram
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Dependence
3 trials -
citalopram
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Major Depressive Disorder
1 trial -
escitalopram
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Addiction
1 trial -
Citalopram
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Depression
1 trial -
Escitalopram
Universal Integrated
Major Depressive Disorder
1 trial -
Modafinil and Escitalopram
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Dependence
1 trial -
Citalopram
United Therapeutics Europe Ltd
Low Mood
1 trial -
Citalopram
COGNITION THERAPEUTICS INC
Antidepressive Agents, Second-Generation
1 trial -
Escitalopram
BRIGHT MINDS BIOSCIENCES INC.
Depressive Disorder, Major
1 trial -
Escitalopram
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Major Depressive Disorder (MDD)
1 trial -
Escitalopram (Oral antidepressant)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Depression - Major Depressive Disorder
1 trial -
Escitalopram Oxalate Tablets
The First People's Hospital of Lianyungang
Major Depressive Disorder
1 trial -
Placebo and Escitalopram
Takeda
Panic Disorder
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.